Healthcare Costs of Long-Acting Insulin Analogs vs NPH Insulin in Type 2 Diabetes Patients Using a Basal Regimen in Denmark

被引：0
|
作者：
Gundgaard, Jens
Aagren, Mark
Thomsen, Trine L.
机构：
来源：
DIABETES | 2009年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A316 / A317
页数：2
相关论文
共 50 条
  • [41] Treatment of Type 1 and Type 2 Diabetes Mellitus with Insulin Detemir, a Long-Acting Insulin Analog
    Young, Jason R.
    McAdam-Marx, Carrie
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2010, 3 : 65 - 80
  • [42] Severe Hypoglycemia Risk With Long-Acting Insulin Analogs vs Neutral Protamine Hagedorn Insulin
    Bradley, Marie C.
    Chillarige, Yoganand
    Lee, Hana
    Wu, Xiyuan
    Parulekar, Shruti
    Muthuri, Stella
    Wernecke, Michael
    MaCurdy, Thomas E.
    Kelman, Jeffrey A.
    Graham, David J.
    JAMA INTERNAL MEDICINE, 2021, 181 (05) : 598 - 607
  • [43] Duration of diabetes and hypoglycaemia rates in type 2 diabetes patients treated with insulin glargine vs NPH insulin
    Dailey, G.
    Aurand, L.
    Garg, S.
    DIABETOLOGIA, 2011, 54 : S262 - S262
  • [44] Long-acting insulin analogs versus intermediate-acting insulin and the risk of major adverse cardiovascular events among patients with type 2 diabetes in the United Kingdom
    Brunetti, Vanessa C.
    Yu, Oriana
    Platt, RobertW
    Filion, Kristian B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 104 - 104
  • [45] Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs
    Poon, Kitty
    King, Allen B.
    DRUG HEALTHCARE AND PATIENT SAFETY, 2010, 2 : 213 - 223
  • [46] Long-acting insulin analogs versus neutral protamine hagedorn insulin and the risk of severe hypoglycemia among patients in type 2 diabetes in the United Kingdom
    Brunetti, Vanessa C.
    Filion, Kristian
    Yu, Oriana Hoi Yun
    Platt, Robert
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 114 - 114
  • [47] Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women With Type 2 Diabetes
    Wu, Jennifer W.
    Azoulay, Laurent
    Majdan, Agnieszka
    Boivin, Jean-Francois
    Pollak, Michael
    Suissa, Samy
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (32) : 3647 - +
  • [48] Therapy: Diabetic ketoacidosis, long-acting insulin analogs and pediatric type 1 diabetes mellitus
    Wilson C.
    Nature Reviews Endocrinology, 2010, 6 (6) : 298 - 298
  • [49] Insulin Degludec, a Long-Acting Once-Daily Basal Analogue for Type 1 and Type 2 Diabetes Mellitus
    Berard, Lori
    MacNeill, Gail
    CANADIAN JOURNAL OF DIABETES, 2015, 39 (01) : 4 - 9
  • [50] Cost advantages and improved patient treatment satisfaction with insulin glargine in type 2 diabetes patients.: The long-acting insulin glargine vs. NPH insulin cost evaluation study in Germany (LIVE-DE)
    Scholten, T.
    Kohlmann, T.
    Moock, J.
    Holle, R.
    Landgraf, W.
    Pirk, O.
    Hauner, H.
    DIABETOLOGIA, 2008, 51 : S405 - S405
12345